Compare Herbalife Nutrition Ltd (HLF) vs Lennar Corporation (LEN) Price & Performance

Herbalife (HLF) trades at $12.65, up 0.56% with a bullish technical signal supported by moving averages. The company shows solid fundamentals with a low P/E of 8.11 and P/S of 0.26, though recent earnings have been mixed with two misses and one beat. A $250 million share repurchase program and CEO transition in October 2026 highlight ongoing corporate developments. Cash flow trends show improvement with projected positive net cash flow of $50 million in 2026.

HLF presents a value opportunity with discounted valuation metrics and analyst consensus target of $19.00 (50% upside). However, risks include negative shareholder equity, high debt levels, and inconsistent earnings performance. The stock offers potential for investors comfortable with turnaround execution risks in the wellness sector.

Lennar Corporation (LEN) trades at $76.13, down 1.65% on the day, with a bearish technical outlook despite appearing fundamentally undervalued with a P/E of 14.7 and P/B of 0.86. Recent earnings have missed expectations for three consecutive quarters, with Q3 2026 results pending. Revenue declined to $34.19 billion in 2025 with net income falling to $2.08 billion, though Berkshire Hathaway has significantly increased its stake, now owning over 11% of the homebuilder.

The stock presents a value opportunity given its below-book valuation and strong institutional backing, but faces headwinds from rising mortgage rates, weak housing sentiment, and recent allegations regarding sales practices. Analyst consensus is mixed with a $77.38 price target slightly above current levels, though technical indicators suggest near-term pressure with support at $74-75.